Medical Education Grants – Generalized Pustular Psoriasis (GPP)
Independent Medical Education (IME) Grants
Boehringer Ingelheim is proud to provide Independent Medical Education (IME) Grant support for evidence-based, fair-balanced, unbiased healthcare professional (HCP) education to help close clinical and practice gaps, improve the quality and delivery of patient care, and enhance behavioral change.
An independent educational program includes both continuing medical education (CME) and non-CME programs. These programs may be at the national, regional, or local level and may include didactic presentations (eg, symposia at educational meetings, grand rounds, and regional workshops), web-based programs, print and electronic monographs, and innovative educational formats.
Clinical Characteristics & Chronic Nature of GPP
-
Increase the healthcare team’s knowledge of the clinical characteristics of GPP (i.e., heterogeneity of presentation, skin of color, chronicity of disease)
-
Advance the healthcare team’s understanding of pathophysiological findings, role of IL36, biomarkers, and quality of life impact (including mental health burden) in GPP that differentiates it from other conditions including plaque psoriasis
- Improve the healthcare team’s knowledge of clinical tools and biomarkers to evaluate the disease and clinical response over time
Clinical Management
-
Increase the healthcare team’s knowledge of the chronic and recurrent nature of GPP, emphasizing the need for long-term management strategies
- Increase the healthcare team’s understanding of clinical research related to potential current and future targeted therapies for the management of patients with GPP
- Improve the healthcare team’s communication with, and education of, GPP patients about their disease and treatment goals and strategies
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.